{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:28:02Z","timestamp":1791282482732,"version":"4.1.0"},"reference-count":45,"publisher":"American Association for Cancer Research (AACR)","issue":"7","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The transcription factor ZNF217 is a candidate oncogene in the amplicon on chromosome 20q13 that occurs in 20% to 30% of primary human breast cancers and that correlates with poor prognosis. We show that Znf217 overexpression drives aberrant differentiation and signaling events, promotes increased self-renewal capacity, mesenchymal marker expression, motility, and metastasis, and represses an adult tissue stem cell gene signature downregulated in cancers. By in silico screening, we identified candidate therapeutics that at low concentrations inhibit growth of cancer cells expressing high ZNF217. We show that the nucleoside analogue triciribine inhibits ZNF217-induced tumor growth and chemotherapy resistance and inhibits signaling events [e.g., phospho-AKT, phospho-mitogen-activated protein kinase (MAPK)] in vivo. Our data suggest that ZNF217 is a biomarker of poor prognosis and a therapeutic target in patients with breast cancer and that triciribine may be part of a personalized treatment strategy in patients overexpressing ZNF217. Because ZNF217 is amplified in numerous cancers, these results have implications for other cancers.<\/jats:p>\n                  <jats:p>Significance: This study finds that ZNF217 is a poor prognostic indicator and therapeutic target in patients with breast cancer and may be a strong biomarker of triciribine treatment efficacy in patients. Because previous clinical trials for triciribine did not include biomarkers of treatment efficacy, this study provides a rationale for revisiting triciribine in the clinical setting as a therapy for patients with breast cancer who overexpress ZNF217. Cancer Discov; 2(7); 638\u201351. \u00a92012 AACR.<\/jats:p>\n                  <jats:p>This article is highlighted in the In This Issue feature, p. 569.<\/jats:p>","DOI":"10.1158\/2159-8290.cd-12-0093","type":"journal-article","created":{"date-parts":[[2012,5,10]],"date-time":"2012-05-10T23:56:49Z","timestamp":1336694209000},"page":"638-651","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression"],"prefix":"10.1158","volume":"2","author":[{"given":"Laurie E.","family":"Littlepage","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"},{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Adler","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosein","family":"Kouros-Mehr","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqing","family":"Huang","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"},{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Chou","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"},{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl R.","family":"Krig","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obi L.","family":"Griffith","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Korkola","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Qu","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon A.","family":"Lawson","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"},{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xue","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Sternlicht","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"},{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit J.P.","family":"Dijkgraaf","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Yaswen","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope S.","family":"Rugo","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen A.","family":"Sweeney","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin C.","family":"Collins","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe W.","family":"Gray","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"},{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard Y.","family":"Chang","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"},{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zena","family":"Werb","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"},{"name":"Authors' Affiliations:\u20081Department of Anatomy, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 3Program in Epithelial Biology, Stanford University School of Medicine, Stanford; 4Divison of Basic Sciences, University of California at Davis Cancer Center, Sacramento; 5Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California; and 6Howard Hughes Medical Institute, Chevy Chase, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2012,7,10]]},"reference":[{"key":"2022060622473165800_bib1","doi-asserted-by":"crossref","first-page":"8703","DOI":"10.1073\/pnas.95.15.8703","article-title":"Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma.","volume":"95","author":"Collins","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060622473165800_bib2","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1101\/gr.174301","article-title":"Comprehensive genome sequence analysis of a breast cancer amplicon","volume":"11","author":"Collins","year":"2001","journal-title":"Genome Res"},{"key":"2022060622473165800_bib3","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1073\/pnas.98.4.1454","article-title":"CoREST is an integral component of the CoREST- human histone deacetylase complex","volume":"98","author":"You","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060622473165800_bib4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nature01550","article-title":"Coordinated histone modifications mediated by a CtBP co-repressor complex","volume":"422","author":"Shi","year":"2003","journal-title":"Nature"},{"key":"2022060622473165800_bib5","doi-asserted-by":"crossref","first-page":"8159","DOI":"10.1128\/MCB.00680-06","article-title":"Specific recognition of ZNF217 and other zinc finger proteins at a surface groove of C-terminal binding proteins","volume":"26","author":"Quinlan","year":"2006","journal-title":"Mol Cell Biol"},{"key":"2022060622473165800_bib6","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1038\/sj.onc.1210126","article-title":"Biochemical characterization of the zinc-finger protein 217 transcriptional repressor complex: identification of a ZNF217 consensus recognition sequence","volume":"26","author":"Cowger","year":"2007","journal-title":"Oncogene"},{"key":"2022060622473165800_bib7","doi-asserted-by":"crossref","first-page":"6066","DOI":"10.1128\/MCB.00246-08","article-title":"Genome analysis identifies the p15ink4b tumor suppressor as a direct target of the ZNF217\/CoREST complex","volume":"28","author":"Thillainadesan","year":"2008","journal-title":"Mol Cell Biol"},{"key":"2022060622473165800_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4161\/epi.4.2.7953","article-title":"The ZNF217 oncogene is a candidate organizer of repressive histone modifiers","volume":"4","author":"Banck","year":"2009","journal-title":"Epigenetics"},{"key":"2022060622473165800_bib9","first-page":"1250","article-title":"The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells","volume":"61","author":"Nonet","year":"2001","journal-title":"Cancer Res"},{"key":"2022060622473165800_bib10","doi-asserted-by":"crossref","first-page":"9703","DOI":"10.1074\/jbc.M611752200","article-title":"Identification of genes directly regulated by the oncogene ZNF217 using chromatin immunoprecipitation (ChIP)-chip assays","volume":"282","author":"Krig","year":"2007","journal-title":"J Biol Chem"},{"key":"2022060622473165800_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ccr.2006.10.009","article-title":"Genomic and transcriptional aberrations linked to breast cancer pathophysiologies","volume":"10","author":"Chin","year":"2006","journal-title":"Cancer Cell"},{"key":"2022060622473165800_bib12","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1158\/1535-7163.MCT-06-0126","article-title":"Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer","volume":"5","author":"Sorlie","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"2022060622473165800_bib13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.stem.2008.02.009","article-title":"Module map of stem cell genes guides creation of epithelial cancer stem cells","volume":"2","author":"Wong","year":"2008","journal-title":"Cell Stem Cell"},{"key":"2022060622473165800_bib14","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1242\/jcs.02532","article-title":"On mammary stem cells","volume":"118","author":"Woodward","year":"2005","journal-title":"J Cell Sci"},{"key":"2022060622473165800_bib15","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1128\/MCB.00040-08","article-title":"Musashi1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the Wnt and Notch pathways","volume":"28","author":"Wang","year":"2008","journal-title":"Mol Cell Biol"},{"key":"2022060622473165800_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1083\/jcb.200611114","article-title":"Evidence for a stem cell hierarchy in the adult human breast","volume":"177","author":"Villadsen","year":"2007","journal-title":"J Cell Biol"},{"key":"2022060622473165800_bib17","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1101\/gad.1795909","article-title":"The Par3\/aPKC interaction is essential for end bud remodeling and progenitor differentiation during mammary gland morphogenesis","volume":"23","author":"McCaffrey","year":"2009","journal-title":"Genes Dev"},{"key":"2022060622473165800_bib18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1101\/gad.952602","article-title":"Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties","volume":"16","author":"Gudjonsson","year":"2002","journal-title":"Genes Dev"},{"key":"2022060622473165800_bib19","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature03799","article-title":"Genes that mediate breast cancer metastasis to lung","volume":"436","author":"Minn","year":"2005","journal-title":"Nature"},{"key":"2022060622473165800_bib20","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jnci\/djn123","article-title":"Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy","volume":"100","author":"Li","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"2022060622473165800_bib21","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1200\/JCO.2006.05.6861","article-title":"Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer","volume":"24","author":"Hess","year":"2006","journal-title":"J Clin Oncol"},{"key":"2022060622473165800_bib22","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1038\/onc.2010.289","article-title":"ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells","volume":"29","author":"Krig","year":"2010","journal-title":"Oncogene"},{"key":"2022060622473165800_bib23","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1093\/hmg\/ddi352","article-title":"ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction","volume":"14","author":"Huang","year":"2005","journal-title":"Hum Mol Genet"},{"key":"2022060622473165800_bib24","first-page":"3147","article-title":"Phase I evaluation and clinical pharmacology of tricyclic nucleoside 5-phosphate using a weekly intravenous regimen","volume":"46","author":"Schilcher","year":"1986","journal-title":"Cancer Res"},{"key":"2022060622473165800_bib25","first-page":"3608","article-title":"Phase I study of tricyclic nucleoside phosphate using a five-day continuous infusion schedule","volume":"44","author":"Feun","year":"1984","journal-title":"Cancer Res"},{"key":"2022060622473165800_bib26","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s10637-010-9479-2","article-title":"Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors containing activated AKT","volume":"29","author":"Garrett","year":"2011","journal-title":"Invest New Drugs"},{"key":"2022060622473165800_bib27","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF00688325","article-title":"Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer","volume":"37","author":"Hoffman","year":"1996","journal-title":"Cancer Chemother Pharmacol"},{"key":"2022060622473165800_bib28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ccr.2006.10.008","article-title":"A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes","volume":"10","author":"Neve","year":"2006","journal-title":"Cancer Cell"},{"key":"2022060622473165800_bib29","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1158\/1078-0432.CCR-06-2837","article-title":"Preclinical testing of clinically applicable strategies for overcoming trastuzumab resistance caused by PTEN deficiency","volume":"13","author":"Lu","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2022060622473165800_bib30","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1158\/1078-0432.CCR-10-2544","article-title":"Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice","volume":"17","author":"Balasis","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2022060622473165800_bib31","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1158\/0008-5472.CAN-04-0343","article-title":"Akt\/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt","volume":"64","author":"Yang","year":"2004","journal-title":"Cancer Res"},{"key":"2022060622473165800_bib32","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/cdd.2010.63","article-title":"The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane","volume":"17","author":"Berndt","year":"2010","journal-title":"Cell Death Differ"},{"key":"2022060622473165800_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ccr.2010.05.023","article-title":"4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors","volume":"18","author":"She","year":"2010","journal-title":"Cancer Cell"},{"key":"2022060622473165800_bib34","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1158\/1078-0432.CCR-09-0317","article-title":"In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models","volume":"15","author":"Hoeflich","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2022060622473165800_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10549-009-0460-8","article-title":"Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines","volume":"121","author":"Hollestelle","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"2022060622473165800_bib36","doi-asserted-by":"crossref","first-page":"e3065","DOI":"10.1371\/journal.pone.0003065","article-title":"Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling.","volume":"3","author":"She","year":"2008","journal-title":"PLoS One"},{"key":"2022060622473165800_bib37","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/ijc.22300","article-title":"Multiple roles of the candidate oncogene ZNF217 in ovarian epithelial neoplastic progression","volume":"120","author":"Li","year":"2007","journal-title":"Int J Cancer"},{"key":"2022060622473165800_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0012-1606(03)00116-7","article-title":"Microarray analysis of somitogenesis reveals novel targets of different WNT signaling pathways in the somitic mesoderm","volume":"258","author":"Buttitta","year":"2003","journal-title":"Dev Biol"},{"key":"2022060622473165800_bib39","doi-asserted-by":"crossref","first-page":"15853","DOI":"10.1073\/pnas.2136825100","article-title":"Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells","volume":"100","author":"Li","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060622473165800_bib40","doi-asserted-by":"crossref","first-page":"e1000121","DOI":"10.1371\/journal.pbio.1000121","article-title":"Regulation of mammary stem\/progenitor cells by PTEN\/Akt\/beta-catenin signaling.","volume":"7","author":"Korkaya","year":"2009","journal-title":"PLoS Biol"},{"key":"2022060622473165800_bib41","doi-asserted-by":"crossref","first-page":"17396","DOI":"10.1073\/pnas.0608607103","article-title":"Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models","volume":"103","author":"Du","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060622473165800_bib42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10911-010-9175-z","article-title":"Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi\/)CD24 (lo\/-) stem cell phenotype in human breast cancer","volume":"15","author":"Blick","year":"2010","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2022060622473165800_bib43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc2620","article-title":"Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits","volume":"9","author":"Polyak","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"2022060622473165800_bib44","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"2022060622473165800_bib45","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"}],"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/2\/7\/638\/1817475\/638.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/2\/7\/638\/1817475\/638.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T18:47:58Z","timestamp":1654541278000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/2\/7\/638\/3157\/The-Transcription-Factor-ZNF217-Is-a-Prognostic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,1]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7,10]]},"published-print":{"date-parts":[[2012,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-12-0093","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2159-8290.c.6545823","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22528968.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22528950.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22528947.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22528971.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22528959","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22528947","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22528956.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22528956","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22528953.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22528962.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22528968","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22528962","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22528953","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22528959.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.c.6545823.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22528971","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22528950","asserted-by":"object"}]},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,1]]}}}